These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22096929)

  • 1. [Iron reduction therapy by phlebotomy for chronic hepatitis C].
    Yano M; Yoshioka K; Hayashi H
    Nihon Rinsho; 2011 May; 69 Suppl 4():262-6. PubMed ID: 22096929
    [No Abstract]   [Full Text] [Related]  

  • 2. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
    Yano M; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Shiono Y; Arao M; Ukai K; Ito H; Watanabe K; Yoshioka K
    Am J Gastroenterol; 2002 Jan; 97(1):133-7. PubMed ID: 11808937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
    Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I
    Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
    Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
    Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
    Di Bisceglie AM; Bonkovsky HL; Chopra S; Flamm S; Reddy RK; Grace N; Killenberg P; Hunt C; Tamburro C; Tavill AS; Ferguson R; Krawitt E; Banner B; Bacon BR
    Hepatology; 2000 Jul; 32(1):135-8. PubMed ID: 10869301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phlebotomy, dietary iron restriction therapy and bovine lactoferrin therapy for chronic hepatitis C].
    Kaito M; Iwasa M; Adachi Y; Iwata K; Yamauchi K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):534-9. PubMed ID: 15359857
    [No Abstract]   [Full Text] [Related]  

  • 7. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
    Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G
    Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phlebotomy: a promising treatment for chronic hepatitis C.
    Tanaka N; Kiyosawa K
    J Gastroenterol; 2004 Jun; 39(6):601-3. PubMed ID: 15235885
    [No Abstract]   [Full Text] [Related]  

  • 9. A pilot study of iron depletion as adjuvant therapy in chronic hepatitis C patients not responding to interferon.
    Guyader D; Boucher E; André P; Even C; Cottereau J; Bianchi A; Gasser P; Mendler MH; Deugnier Y; Brissot P
    Am J Gastroenterol; 1999 Jun; 94(6):1696-8. PubMed ID: 10364051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of iron in the natural history and clinical course of hepatitis C disease.
    Shedlofsky SI
    Hepatogastroenterology; 1998; 45(20):349-55. PubMed ID: 9638405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
    Yano M; Hayashi H; Yoshioka K; Kohgo Y; Saito H; Niitsu Y; Kato J; Iino S; Yotsuyanagi H; Kobayashi Y; Kawamura K; Kakumu S; Kaito M; Ikoma J; Wakusawa S; Okanoue T; Sumida Y; Kimura F; Kajiwara E; Sata M; Ogata K
    J Gastroenterol; 2004 Jun; 39(6):570-4. PubMed ID: 15235875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The advantage of gastrectomized patients in management of their chronic hepatitis C.
    Hayashi H; Takikawa T; Arai N; Yano M
    Nagoya J Med Sci; 1997 Nov; 60(3-4):119-27. PubMed ID: 9481091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy.
    Tsai NC; Zuckerman E; Han SH; Goad K; Redeker AG; Fong TL
    Am J Gastroenterol; 1997 Oct; 92(10):1831-4. PubMed ID: 9382046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
    Imazeki F
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):540-3. PubMed ID: 15359858
    [No Abstract]   [Full Text] [Related]  

  • 15. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
    Fontana RJ; Israel J; LeClair P; Banner BF; Tortorelli K; Grace N; Levine RA; Fiarman G; Thiim M; Tavill AS; Bonkovsky HL
    Hepatology; 2000 Mar; 31(3):730-6. PubMed ID: 10706565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron reduction therapy in hepatitis C.
    Lurie Y; Beer Gabel M; Lambort I; Soumatzky T; Malnick SD; Bass DD
    Gut; 1998 May; 42(5):759-60. PubMed ID: 9659182
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
    Girelli CM; Mirata C; Casiraghi A
    Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phlebotomy for chronic hepatitis C].
    Kawabe N; Hashimoto S; Murao M; Yoshioka K
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():278-83. PubMed ID: 26845945
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study].
    Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J
    Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C.
    Kaito M; Iwasa M; Kobayashi Y; Fujita N; Tanaka H; Gabazza EC; Adachi Y; Kojima Y; Nakagawa N; Watanabe S
    J Gastroenterol; 2006 Sep; 41(9):921-2. PubMed ID: 17048059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.